NAT-BENDAMUSTINE
NAT-BENDAMUSTINE
Approved
DIN Number
02496887
Drug Class
Human
Market Date
Feb 25, 2021
Company
HC
natco pharma (canada) inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02496887
AIG Number0153268001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01AA09 BENDAMUSTINE
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
BENDAMUSTINE HYDROCHLORIDEActive
Strength: 25 MG / VIAL
Monograph: BENDAMUSTINE HYDROCHLORIDE